Meet Prescient

Debasish is our Chief Executive Officer. A physician by training, Debasish is a seasoned strategy advisor to biopharmaceutical leadership with 20 years of industry and consulting experience. After a brief stint early in his career at P&G, Debasish spent a decade with Bain & Company, where he was a leader in the healthcare practice. Debasish has extensive international experience across the US, EU and APAC markets advising biopharmaceutical leaders on value creation through corporate, business unit, disease area and product-focused strategies.

Alex is our Chief Financial Officer. After studying at the London School of Economics and qualifying as a chartered accountant at KPMG, he spent over 20 years working for large multinational organizations, including Thorn EMI, BAA and Lend Lease. He most recently spent 14 years at the global sustainability consultancy ERM, where he successfully supported the business through three private equity transactions.

Gerald is our Chief Strategy Officer. He is a molecular biologist by training and completed his PhD in anti-microbial drug discovery under the highly regarded Glaxo Scholarship program. After several years of working across drug discovery and development, both in Europe and in North America, Gerald transitioned to the world of management consulting. Since then, he has spent the last 20 years working exclusively in the healthcare and life sciences sectors, including leading practices at McKinsey & Company and KPMG, serving clients across the value chain encompassing R&D strategy, clinical development strategy, portfolio strategy, medical affairs strategy and value and access strategy. At Prescient, Gerald leads the charge in shaping and executing our ambitious growth strategy to deliver on our vision and mission.

Paul is our Chief Commercial Officer. Since completing his PhD in chemistry at Stony Brook University, he has spent more than 25 years providing guidance and support to the healthcare industry. He has held leadership roles at various consulting firms, such as Deloitte and Quintiles, that engage with biopharmaceutical and medical technology companies in nearly all functional areas, including sales, marketing, medical affairs, business development and supply chain. Paul’s focus at Prescient is helping our clients achieve and sustain peak commercialization targets across a wide range of therapy areas.

Steve is our Chief Operating Officer. Prior to this, he was Managing Director and one of the founding partners of Strategic North. He spent the first part of his career in brand and innovation consultancy, working with a range of international brand-led businesses. He brings a forward-looking and customer-centric brand mindset to everything we do. With over 30 years of experience, Steve is quick to see the big picture, never one to accept the status quo and a passionate believer in the power of teams – all qualities he brings to bear on everything he does, whether it’s for your brand or ours.

Erica is the Head of our Global Commercial Practice. She earned her PhD from Princeton University in cognitive psychology and her MBA from MIT Sloan. She has 20 years of experience in healthcare consulting and biotechnology, including eight years at the Boston Consulting Group, where she served as the North America topic leader for launch in biopharma. Prior to joining Prescient, Erica was a Vice President at Zymergen, where she led strategy and managed technical delivery teams. She specializes in biopharma product and portfolio strategy and has experience across many therapeutic areas. At Prescient, Erica focuses on uncovering and understanding the drivers of decision making and translating them into actionable recommendations for clients.

Jamie is our Founder and Corporate Development Officer. He has spent more than 20 years leading, growing and managing pharma-focused insight and advisory firms. In 2007, he became the managing director of a global competitive strategy firm and led the company’s transition from an industry generalist to a biopharmaceutical specialist. He rebranded the company as Prescient in 2010, led a management buyout in 2014 and investments by Baird Capital and Bridgepoint Development Capital in 2017 and 2021, respectively.
During his tenure as Chief Executive Officer, Jamie drove more than 20 consecutive quarters of growth. He guided the acquisition of Strategic North, a specialist provider of brand strategy and research services, and the expansion of Prescient’s suite of offerings to support a range of pharma functions, including medical affairs, clinical development, early commercial, global marketing, competitive intelligence and market research. Jamie continues to sit on our Board of Directors and provides management with support and guidance.

Ben is the Head of our Global Insights Practice. He holds a BSc in biomedical sciences and an MSc in biomedical engineering, and he gained eight years of experience in biotechnology prior to joining Prescient in 2010. Ben has held progressively more senior roles at Prescient, which has given him a deep understanding of what is needed to build and motivate teams that deliver results with a high degree of client satisfaction. Ben is closely involved in managing projects across multiple therapeutic areas, including oncology, immunology and biosimilars.

Swati is the Head of our Global Data, Analytics and Technology Practice. She has an MSc in biotechnology and pharmacology and an MBA from the University of Sheffield. After joining us in London in 2008, Swati moved to India in 2010 to set up the New Delhi office, which she has built into a critical part of our business. She has also been responsible for setting up the InflexionRx® Software Development and Prescient Data & Analytics teams in India. Swati has extensive experience in consulting biopharma companies on new and mature brand planning strategies. She directs engagements across multiple therapeutic areas and geographies, with a focus on the APAC region.

Luke is the Head of our Global Medical Practice. After studying medicine and working as a doctor in the UK for several years, Luke took on consulting roles at various firms, including McKinsey & Company and Strategy&, as well as a regional role at AstraZeneca. Though he now focuses on medical, he has led and delivered projects across most of the pharmaceutical value chain and in multiple therapy areas and geographies. Luke brings deep experience in medical, portfolio and clinical development strategy, evidence generation, and life cycle management. Luke is still a clinician at heart and loves nothing more than supporting our clients to ensure innovative medicines reach the patients that need them.

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgery before joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Alan is a Founder Partner of Bridgepoint Development Capital (BDC). He has a degree in finance from Birmingham University and is a chartered accountant. He sits on the BDC Board, Operating Committee and is a member of its Investment Advisory Committee. Alan joined BDC in 1996 and is currently a board member of portfolio companies Matrix and HKA. He has led a broad range of transactions including public to private and serial international buy and build investments. Previous transactions include Quotient Clinical, Phlexglobal, LOC Group, BigHand, The Energy Solutions Group, Pulsant and Safestore PLC. Prior to joining BDC, he worked for Deloitte (formerly Arthur Andersen) in its corporate finance team.

Michael is a Senior Associate at Bridgepoint Development Capital, where he is a member of the Services investment team. He holds a degree in English language and literature from Oxford University. Michael joined the firm in 2017 and, since joining, has been involved in several transactions, including the investments in Prescient Healthcare Group, Analysys Mason and Achilles, the add-on acquisition of The Kenrich Group for HKA and the subsequent sale of HKA to PAI Partners. Prior to Bridgepoint Development Capital, he was an Associate in the Financial Sponsors Group at HSBC, where he advised private equity clients on several M&A and leveraged finance transactions.

Rakesh serves on Prescient’s Board as a Non-Executive Director. After earning a degree in veterinary medicine, he completed his MS in immunology and his PhD in immunology/oncology at Imperial College, School of Medicine, London. He was then recruited by oncology biotechnology firm Antisoma, which specialized in the development of antibodies-based therapeutics for oncology. After working in oncology drug development for more than a decade, Rakesh joined Prescient in 2007. His renowned expertise in the development and commercialization of biologics makes him an extremely valuable asset to our oncology, immunology and biosimilar clients.

Debbie is a Senior Vice President at Prescient. She has a track record spanning more than 25 years and a variety of global and national marketing roles at AstraZeneca. She then leapt into the consultancy world, where she created a successful brand-building and insights firm called Strategic North with co-founders David, Steve and Michael. Debbie is passionate about collaborating with clients to build successful brands starting early in the life cycle through launch and beyond, bringing substantial knowledge and experience creating actionable strategies that achieve tangible results.

Kevin is a Vice President and leads our Boston office. He earned his BSc in neuroscience and economics from Brown University and has since worked in life sciences and biopharmaceutical strategy consulting, spending the better part of a decade at ClearView Healthcare Partners before joining Prescient. Kevin has led multiple engagements across a range of therapeutic areas and geographies. He has particular expertise in early commercial, commercial and medical strategy, and is experienced in target product profile development and evaluation, therapeutic area and indication prioritization, competitive and clinical development strategy, opportunity assessment, due diligence and life cycle management. At Prescient, Kevin ensures client satisfaction through tailored high-quality recommendations.

Harminder is a Vice President and has been delivering high-impact projects to our clients since 2010. He earned his MS in chemistry from Virginia Commonwealth University and his BPharm from Panjab University. He is also a registered pharmacist. Before joining Prescient, he worked in pharmaceutical product manufacturing, regulatory and corporate departments. At Prescient, Harminder focuses on building client relationships by understanding clients’ needs and motivating our teams to better serve their requirements through our standardized work methodologies.

Simon, a marketing strategy specialist, is a Vice President at Prescient. His career history includes seven years in FMCG, 12 years “client side” in pharma in a range of global and US leadership positions and over eight years in strategy consulting. Simon joined Strategic North in 2016 and has led a range of projects across the product life cycle. He specializes in brand planning, positioning, competitor strategy, value proposition development and brand activation.

Courtney is an Associate Vice President of Operations. She previously worked as a technical translator in Bogotá, Colombia. Since joining Prescient in 2012, she has become involved in various parts of the business, including quality control, resourcing and compliance. She is responsible for minimizing ethical, contractual and reputational risks for Prescient.

Katy is a Vice President at Prescient. Since earning her master’s degree in bioscience from Keck Graduate Institute, she has acquired several years of experience in life science consulting, advising clients on product and portfolio strategies. She has focused on late-stage, pre-launch assets across various disease areas, including oncology, hematology and ophthalmology. At Prescient, Katy’s focus is on driving our value to our medical affairs clients and growing our team, expanding Prescient’s presence and supporting teams’ professional development.

David is a Senior Vice President at Prescient and prior to that was a founding partner and Client Relationship Director at Strategic North. He has over 25 years of experience in the pharma industry across market research and strategic brand building. He is part of a leadership team that built three successful pharma consultancy practices. He brings deep expertise in understanding customer beliefs and behaviors and translating these insights into brand strategy. He combines this expertise with great people skills to ensure clients are inspired about the future possibilities for their brand. David is passionate about engaging with a diverse range of stakeholders in healthcare and positively impacting patients’ lives.

Easha is an Associate Vice President at Prescient. She has a degree in life sciences and an MBA in marketing and strategy from the Indian School of Business. She has more than 12 years of industry experience and a proven track record of turning compelling market insights into differentiated strategies and solutions. She has worked across the business value chain from R&D, new product launch and commercialization to life cycle management of brands in various therapy areas. She has held strategic and marketing roles in various biopharmaceutical companies and led the launches of two blockbuster products in oncology. At Prescient, Easha directs global competitive intelligence programs for leading biopharmaceutical companies.

Olga is an Associate Vice President at Prescient. She is a medical doctor with a master’s degree in medicine of the pharmaceutical industry from the Autonomous University of Barcelona. She has also completed the IESE Management Development Program and ESADE Leadership and Marketing master’s. She has more than 30 years of experience working in the pharmaceutical industry in both large multinational and medium-sized companies such as Sanofi, Lundbeck and Ferrer, as well as at the consultancy firm KPMG, where she held various leadership positions. She has deep experience at the international level across the whole pharmaceutical value chain in multiple therapy areas. At Prescient, Olga is responsible for championing the development of the Barcelona-based team, contributing to growing our European business and supporting our clients to address their strategic and operational challenges.

John is an Associate Vice President with 20 years of experience in partnering with healthcare clients across insight and strategy workstreams at a local, regional and global level. John has a passion for developing new research methodologies to unravel why customers behave the way they do. He also has a flair for developing impactful deliverables that galvanize teams and facilitating action-orientated workshops that drive alignment around decision making. John has been nominated for and received numerous awards for his work and has spoken at BHBIA and EphMRA conferences.

Jatin is an Associate Vice President at Prescient and has been with us since 2014. He holds a master’s degree in biotechnology from the University of Manchester and has worked in the pharmaceutical analysis divisions of major organizations, such as Bloomberg. At Prescient, Jatin has directed several global projects while working across domains, including immunology, oncology, hematology, neurology, nephrology, endocrinology, respiratory disease and biosimilars. He applies his broad experience across functions and his strategic mindset to a variety of engagement types, like commercial strategy development workshops and intelligence-driven consultative projects.

Gareth is an Associate Vice President at Prescient. He joined Strategic North in August 2014 and has over 12 years of experience in pharmaceutical brand strategy and market research. Gareth is passionate about ensuring customer understanding is at the heart of strategic decision making. He drives alignment and clarity across client teams, enabling consistent implementation. At Prescient, Gareth is a champion of our company’s culture and values and an indispensable ally to our clients.

Mark is the Senior Vice President of our North American business. After completing a PhD in biochemistry at The Ohio State University, he spent more than 10 years running GSK’s competitive strategy function and 10 years as a key member of Covance’s executive strategy and business intelligence team. Mark engaged with Prescient throughout his tenure with GSK and Covance before joining us in 2013. He is responsible for establishing, solidifying and expanding client relationships by engaging with industry executives and bringing clarity to our solutions.

Cameron is an Associate Vice President at Prescient. He earned his PhD in biophysical chemistry from the University of Glasgow, his MSc in chemistry from the University of Strathclyde and his MBA from Strathclyde Business School. He has over 17 years of experience in the pharmaceutical and biotechnology industries, having worked for both established firms and start-ups in R&D, manufacturing, BD, licensing and IP management. At Prescient, Cameron is responsible for leading high-quality engagements with new and existing clients and applying his knowledge and experience to answer their strategic business questions.

Aviral is a Vice President at Prescient. He is a seasoned medical expert with extensive knowledge across various therapeutic areas, including cardiology and metabolism, respiratory, dermatology, rheumatology, immunology, oncology, gastroenterology, neurology and ophthalmology. Since joining Prescient in 2010, Aviral has worked on a variety of projects. He possesses in-depth knowledge and expertise in all aspects of clinical development, commercialization strategies and market access, both in developed and emerging markets. Besides his consultancy work at Prescient, Aviral has worked for GSK and Grail Research as a medical and commercial lead. He also practiced as a physician for nearly eight years, played a key role in setting up a new state-of-the-art trauma hospital in India, and coordinated several public health projects with the Indian government.

Andrew joined our team in 2012 after holding finance director positions in marketing services companies like Publicis and Gyro. He is a qualified chartered accountant and holds an honors degree in accountancy from Dundee University. He was heavily involved in setting up the shared resources service center in the UK, arranging Prescient’s de-merger/MBO in 2014 and taking Prescient through two rounds of private equity investments in 2017 and 2021. He manages Prescient’s finances and is the company’s secretary.

Victoria is our Chief Talent Officer. She has a bachelor’s degree (with honors) in economics from Nottingham Trent University, is a Fellow Chartered Accountant  and holds numerous human resources certifications and accreditations. Victoria spent more than 20 years in senior leadership positions at KPMG across the EU and Asia, where she developed extensive experience and a proven ability to implement change in complex and cross-cultural environments. At Prescient, her role involves working with senior stakeholders to effectively prioritize and execute the activities needed to achieve defined strategic objectives.

Tarun is Head of Software development at Prescient. He obtained his master’s degree in computer applications from M.B.M Engineering College and has more than 22 years of experience in the product engineering, design and development of cloud-based enterprise systems and entrepreneurship. He is an expert in product ideation, conceptualization, development from proof of concept to final products and market releases. At Prescient, Tarun is spearheading the development of our InflexionRx® platform. His role involves leading and delivering a software platform that creates value for our clients and drives efficiency among our project teams.

Jeanne is a Vice President at Prescient. Prior to joining Prescient, she spent more than 25 years providing strategic insight and planning support to the biopharmaceutical industry. Jeanne has held leadership roles at various companies, including EMD Serono and Genzyme. She brings a depth of biopharmaceutical experience in brand and strategic planning, indication prioritization, competitive intelligence, workshop design and facilitation, and the integration of multiple external perspectives to inform decision making. At Prescient, Jeanne leverages her expertise in rare diseases, multiple sclerosis, immunology, hematology and oncology to grow and develop client relationships and lead client engagements.

Elisavet is a Vice Prescient who joined Prescient in 2008. She holds a PhD in molecular immunology and an MSc in medical genetics from Brunel University London, as well as a BSc in biology from the Royal Holloway University of London. As a consultant in the pharmaceutical industry, Elisavet has gained extensive experience in various aspects of drug development and commercialization, strategic marketing and life cycle management, providing critical analyses and recommendations to brand teams supporting new and existing products in oncology, malignant and non-malignant hematology, vaccines, rare diseases and other areas. At Prescient, Elisavet uses her expertise in evidence gathering to identify key unmet needs, gaps in strategy, opportunities for differentiation and potential threats.

Having joined in 2002, Anthony, a Vice President at Prescient, is one of the longest-serving members of our team. He earned his PhD in pharmacology before becoming a postdoctoral researcher at the University of Southampton. From there, he entered the world of healthcare market research, working for the likes of MMR International, IMS Health and NOP World (now GfK). He has consulted across the therapeutic spectrum and throughout the product life cycle but, at Prescient, particularly enjoys developing clinical strategies in oncology, infectious diseases and cardio-metabolic diseases.

Mladen is an Associate Vice President at Prescient. He received his PhD in microbiology from the University of Minnesota and completed his postdoctoral research at Columbia University. Before joining Prescient, Mladen oversaw analyst teams and market research portfolios at Decision Resources Group across various therapeutic areas. He has previously worked at Merck and AstraZeneca/MedImmune, where he led projects focused on the discovery of novel anti-infectives for the treatment and prevention of serious bacterial infections. At Prescient, Mladen is responsible for leading engagements across different therapeutic areas, including oncology, infectious, metabolic, autoimmune and rare diseases.

Michael, a Senior Vice President at Prescient, was founder and Business Unit Director of Strategic North. Michael draws on a wealth of knowledge and experience from building a successful global consultancy, as the Head of Client Services for a healthcare communications agency and being a Global Commercial Lead in corporate, all underpinned by his MBA and degree in biochemistry. He embodies the intellect and creative energy that shapes great brand strategy and has the commercial astuteness to realize the full value of a brand, portfolio or franchise.

Christina is our Head of Global Marketing and leads all marketing and communications functions. After earning a master’s degree in pharmaceutical business, she pursued careers in both the non-profit and commercial sectors. Her experience includes leading marketing strategy for global oncology teams, as well as regionally for the Americas and in emerging markets with Kantar’s Health Division (now Cerner Envisa). Christina is responsible for elevating the positioning and messaging of the Prescient brand through the development of strategic marketing programs and thought leadership initiatives.

Nishika is a Director at Prescient. She holds a bachelor’s degree in life sciences and a master’s degree in microbial technology. She has over eight years of healthcare consulting experience spanning diverse business functions such as strategy consulting, market research and competitive intelligence in various therapeutic areas including immunology, rare diseases, infectious diseases and biosimilars. Apart from healthcare consulting, Nishika has also created comprehensive research books identifying forward-looking strategies in various autoimmune and chronic inflammatory diseases. At Prescient, Nishika directs global competitive intelligence programs focused on clinical development strategy, competitive landscaping, product positioning and market-entry strategies for leading biopharmaceutical companies.

Alyssa is an Associate Director at Prescient. She has a specific interest and expertise in fusing key stakeholder insights into a robust brand strategy. Alyssa has over seven years of brand planning, market research and account management experience in both agency and consultancy settings. She enjoys tackling complex challenges in healthcare and strives to always bring a positive energy to her work. Alyssa is responsible for client management of key accounts and leading teams to build out strategies with clarity and innovation.

Helena is a Consulting Director at Prescient. She brings over 20 years of experience in global pharmaceutical market research and, since joining Strategic North in 2017, brand strategy. Over this time, she has worked in a broad range of therapy areas including oncology, rare diseases, devices and diagnostics, and ophthalmology, and supported brands across their life cycle. Her extensive experience has brought a deep understanding of the demands and challenges clients face, and the importance of engaging and action-oriented deliverables for maximum project benefit. Helena’s inquisitive thinking ensures that all our client’s commercial challenges are explored.

Tanya is a Director at Prescient. She previously served as a corporate communications and investor relations executive for small- and mid-cap pharmaceutical companies, and has more than 15 years of experience as an academic neuroscientist. Since joining Prescient in 2016, Tanya has applied a combination of academic rigor and real-world insight to address her clients’ needs. She has provided dozens of new and mature brand product teams with top-quality business intelligence acquired through research and conference attendance. In her work at Prescient, Tanya is passionate about bridging communication divides between thought leaders and industry experts.

Jyotsana is a Director at Prescient. She has an MSc in clinical research and has worked with IMS Health (now IQVIA) and SmartAnalyst India Pvt Ltd as part of her prior engagements. She has 15 years of experience in oncology research and analytics and has been instrumental in setting up teams and processes for syndicated offerings and customized client engagements. Jyotsana has expertise in clinical trial analysis, insight generation and has been extensively involved in conceptualization, structuring and process layouts for multiple cancer reports and databases, including both solid and hematological malignancies. She is responsible for delivering disease- and mechanism-based competitive landscapes and datasets supporting our product, commercial and therapy area strategy analyses.

Sarah is our Head of People and Culture. She joined Strategic North when it was founded in 2010 and has over 25 years of experience in HR, operations and finance, working with some of the biggest PR and marketing agencies in the UK and Australia. Sarah’s energy, passion and enthusiasm put her at the heart of the Strategic North culture. She is a highly skilled people person, responsible for all elements of our People & Culture strategy, ensuring we recruit, develop and retain the right people to deliver against our overall business strategy. She makes sure that the unique culture we have created is protected and sustained through living our values.

Shweta joined Prescient in 2015 and is a Director. She has a master’s degree in biotechnology and bioinformatics from La Trobe University in Australia. She began her professional career in life sciences consulting more than 12 years ago. Since then, she has been part of several organizations where she supported successful medicine launches that positively impact patients’ lives. Besides consulting, Shweta has experience as a scientific writer and has authored several publications for some of the top brands in pharma. At Prescient, Shweta is responsible for managing key accounts, building and coaching the Prescient team and creating an unmatched, high-quality experience for our clients.

Paula joined our team in 2015 and is now a Director at Prescient. She holds an MSc in medical biology from the University of Oviedo, Spain. She began her academic research career at the University of Roehampton London, investigating the mechanism of metastasis in multiple tumors. At Prescient, Paula coordinates a wide range of engagements with our clients in the oncology space, with a particular focus on drug development strategy and competitive pipeline analysis. She uses her deep knowledge and expertise across treatment paradigms and market dynamics in oncology to advise our clients’ strategies in this area.

Anamika is a Director at Prescient and heads the Talent and Performance Management Function of our India operation. She is an alumna of IIM Raipur and has an MBA in human resource management. She has more than 12 years of experience in human resources and has worked in diverse industries. At Prescient, Anamika is responsible for talent acquisition and development, and she continues to play a pivotal role in the growth and development of our India team.

Gordon is a Senior Director at Prescient. He earned his MBA in marketing and strategy from Carnegie Mellon University and his BA in biochemistry from the University of Pennsylvania. He has over 15 years of dedicated oncology experience in market research and competitive intelligence. Before joining Prescient, Gordon led teams working on projects across the development timeline at Kantar Health, AlphaImpactRx (now part of IQVIA) and Psyma. At Prescient, Gordon is responsible for driving our business’ growth by expanding our presence, ensuring high-quality engagements and supporting team development.

Nadia is a Director at Prescient. She joined our team as the US Financial Controller and HR Director. After earning her accounting degree, she developed financial expertise through her work with high-end retail and luxury brands headquartered in New York City. While working in retail, Nadia was responsible for the financial reporting and oversight of nationally recognized brands. The technical expertise and business acumen she has acquired over the past 15 years have proven to be invaluable assets to our organization.

Lee is a consulting director with over 20 years of experience that spans multiple global roles across pharma and consumer healthcare multinationals. Having worked extensively at the intersection of commercial strategy, emerging science and customer insight, he is well-placed to lead cross-functional client teams through a wide range of strategic challenges. Lee also has significant brand strategy experience in immunology and infectious diseases, working across the development life cycle from early asset development to mature in line brands.

Bharat is a Director at Prescient and has been with us since 2014. He holds an MS in biotechnology and entrepreneurship from New York University. He specializes in oncology, immunology, neuroscience and rare diseases. He has directed several engagements focused on the US, EU and global markets across various areas and topics of interest, including regulatory strategies, clinical development, new product commercialization and mature brand planning. Bharat is responsible for managing key client accounts, driving business growth and leading internal development activities.

Claudio is a Director at Prescient. Since earning his MBA from the IESE Business School and a double BSc degree in chemical and mechanical engineering from the IQS School of Engineering (Universitat Ramon Llull), Claudio has spent his career in consulting roles at various companies, including IQVIA and two of the Big Four professional services firms. He has led and delivered strategy consulting projects across multiple therapy areas, especially in the fields of commercial, portfolio, corporate and market access strategy, commercial excellence/SFE, life cycle management and M&A. At Prescient, Claudio is responsible for building our Spanish team and supporting the growth of our European business.

Rachna is a Director at Prescient. She has a degree in pharmacy and an MBA in pharmaceutical marketing. She has over 10 years of experience in strategic consulting and competitive intelligence spanning various therapeutic areas including oncology, vaccines and biosimilars. At Prescient, Rachna directs global competitive intelligence programs for leading biopharmaceutical companies and is responsible for driving business growth by ensuring high-quality engagements and supporting team development.

Priya is a Director at Prescient. She earned her PhD in molecular biology from the New Jersey Medical School and her MBA in pharmaceutical management and marketing from Rutgers Business School. Priya has over 15 years of healthcare experience, having served as a subject matter expert and trusted advisor for her clients. She has co-authored several peer-reviewed scientific articles and industry-relevant white papers. At Prescient, Priya is responsible for driving growth within our business, managing key business accounts and providing strategic leadership in coaching teams to deliver successful engagements.

Gosha is a Director at Prescient and is responsible for our UK & European HR function. After earning her master’s degree in psychology, she worked in the pharma and signage sectors in the UK and mainland Europe, gaining experience across different functions in HR, including recruitment, performance management, payroll, and employee and labor relations, at a national and international level. Gosha joined Prescient as HR Manager, rising up the ranks as her expertise in managing people has proven invaluable.

Jen is our Business Partner. After completing a natural sciences and management studies degree at Cambridge University, she started her career as a strategy and operations management consultant with Deloitte. Having worked with global clients across industries to deliver a range of finance advisory and transformation projects, she moved to GSK, where she held various transformation and partnering roles in finance services, corporate and, more recently, R&D. Jen is a qualified management accountant (ACMA GCMA) and is PRINCE 2 and Lean Six Sigma certified. At Prescient, Jen acts as a business partner to leadership across the organization; she supports the business in making impactful decisions backed by data and in implementing business improvement initiatives.

Chris is a Consulting Director at Prescient with nine years of experience working with global brand and insights teams to understand market dynamics, opportunities and implications for brand and portfolio development. Chris partners with global clients to support pipeline, pre-launch and in-line brand decision making, portfolio and disease area strategy. He recently partnered with a global commercial capabilities and excellence team to develop a business-wide approach to early asset vision and strategy development. He combines close collaboration and technical understanding with genuine curiosity to learn about the “today and tomorrow” of healthcare and deeply comprehend evolving therapy areas.

Amol is a Director at Prescient and is an expert in strategically supporting clients across the life sciences industry. Prior to joining Prescient, Amol received his PhD in molecular biology and cancer genetics from the Temple University School of Medicine in Philadelphia and completed his postdoctoral research at Mount Sinai School of Medicine in New York, where his thesis focused on the discovery and development of novel oncogenic kinase targets and inhibitors in triple-negative breast cancer. Amol is deeply familiar with the oncology, hematology and inflammatory disease areas, with expertise across various forms of engagements. His primary strategic focuses include early asset, asset life cycle and portfolio/therapeutic area planning. At Prescient, Amol serves as a critical thought partner for clients, leveraging his disease area expertise and strategic insights to drive actionable and innovative solutions.

Navi Singh Parmar is a Director at Prescient. He earned his BA in religion with a minor in political science from Syracuse University and MPH in health management and policy from Drexel University. Before joining Prescient, Navi worked for more than eight years in healthcare management consulting at Deloitte. He is proficient in serving clients strategically and operationally across government programs like Medicare and Medicaid. He brings subject matter expertise on value-based care and population health strategy across the healthcare ecosystem. His specialty is bringing payers, providers and pharma together to improve the accessibility, quality and cost of care. At Prescient, Navi helps our clients solve strategic challenges across various therapy areas.

Chris is a Consulting Director at Prescient. He joined us having spent just under a decade at a global consumer healthcare company working at the intersection of commercial strategy, brand innovation and portfolio management. Chris relishes the opportunity to build collaborative partnerships. He endeavors to uncover human truths behind the data that will resonate with the brand, customer and, ultimately, the patient. Chris has significant experience in oncology, respiratory and rare blood disorder brand strategy across the development life cycle, from early asset development to mature, in line brands.

Kallal is a Senior Director at Prescient and one of the longest-serving members of our India-based team, boasting a wealth of education and experience in his field. He has master’s and doctoral degrees in biotechnology, as well as an MBA. After holding various academic research positions in oncology, Kallal became a Lead Scientist at Connexios Life Sciences, where he designed assays to test the efficacy of in-house drugs. Since joining Prescient in 2010, Kallal has led new and mature product brand planning engagements and workshops in neurology, oncology, immunology, vaccines, virology and diabetes in both regulated and semi-regulated markets.

Emmanuel is a Senior Director at Prescient. He holds an MD from the University of Cincinnati College of Medicine and an MSc in immunology from the Medical University of South Carolina. Emmanuel co-founded a consulting firm to help integrate technology and healthcare, originally centered on the implementation and optimization of electronic health record systems. After several years of growing the business, he entered the pharmaceutical sector as a clinical trial manager. He has experience conducting clinical and preclinical research in molecular biology and liquid tumors. At Prescient, Emmanuel leverages his clinical and research experience to support clients as they navigate the complexities of bringing new therapies to patients in need.

Ben is a Consulting Director in our Commercial Strategy business with a passion to build effective brand and disease area strategies. He is an expert in designing and executing strategy workshops, delivering cross-functional alignment and energizing client teams. Ben is responsible for leading successful partnerships with teams across a range of therapy areas such as oncology, immunology and neuroscience.

Josh is a Consulting Director who specializes in integrating brand strategy with customer insight. His comprehensive expertise and strategic thinking span many disease areas, like cardiometabolic conditions, neurology and hematology, both blockbuster brands and rare disease assets. Motivated by building lasting relationships, he brings a personal approach to understanding unique brand dynamics and challenges to collaboratively uncover the opportunities that lie between brand objectives and customer need. Josh is responsible for overseeing key client accounts and leading teams to deliver fresh and meaningful recommendations to complex questions, informing actionable commercial strategy.

Anna is our Head of Finance & Business Operations. She has strong financial planning and reporting skills, good business acumen and supports the executive board and management team in decision making. Prior to joining Strategic North, Anna trained and qualified for her CIMA accountancy qualification at N Brown Group PLC. Over the course of her more than 20-year career, she has held various roles in finance at Marks & Spencer, TDG and a number of SMEs.

Ranjini is a Director at Prescient. She has a Bachelor of Engineering from the Visvesvaraya National Institute of Technology, India, and a master’s degree in human resources, accredited by the CIPD in the UK. She has spent over 20 years working for large multinational organizations, including PwC, Barclays, KPMG, Vodafone, EDF Energy and the renewable energy company RES. In that time, she has led several large, complex projects through ambiguous and rapidly changing environments and helped clients realize value through their transformation agendas. She has worked in numerous countries across a variety of sectors, enabling transformations stemming from both organic and inorganic growth. At Prescient, Ranjini is responsible for enabling organizational change, working globally to help our teams and leaders deliver on their growth strategies and transformational goals.

Nila is a Consulting Director at Prescient. She joined Strategic North in 2021 and is leading the quant-enabled strategy arm. In her more than 20 years as an insights and brand strategy professional, Nila has worked across a range of geographies and cultures, helping businesses connect the dots between insight and strategy by understanding their key stakeholders and establishing unique ways of communicating with them. Skilled in the application of quant techniques from classic to advanced analytics, Nila leverages technology across the research spectrum to deliver meaningful learnings that drive material improvements in strategy and performance.

Michaela is a Director at Prescient. She earned her Master of Pharmacy degree at the School of Pharmacy in London and holds an MBA from the International University of Applied Sciences in Germany. She has over 17 years of combined pharmaceutical industry and consulting experience, predominantly within medical affairs, working across a range of products, therapy areas and indications. Her added curiosity and extensive language skills have led her to delve into the healthcare compliance and regulatory affairs arena to better understand national regulations, laws and industry codes of practice across European, Middle Eastern and African countries.

Michaela has successfully supported medical education, medical strategy, medical information, functional design and medical governance projects. At Prescient, Michaela’s focus is on supporting the growth of our European business and expanding our presence in Germany.

Ashima, a physician by training, is a Senior Director at Prescient. Her career has included positions with medical institutions, insurance companies and consulting firms. Ashima joined Prescient in 2014 and has since worked extensively in cardiology and metabolism, biosimilars, hematology and rare diseases. She leads client engagements related to strategic BD&L decisions, competitive intelligence, product label design, commercialization planning, life cycle management and financial modelling.

Gaurav is a Director at Prescient. He holds a PhD in nanomedicine from the University of Strathclyde, Glasgow, and an MS in pharmaceutics from the National Institute of Pharmaceutical Education and Research (NIPER). Prior to joining Prescient, Gaurav served as a Feasibility Specialist at Syneos Health, a Pfizer business unit, where he provided insights and recommendations in hematological malignancies trials; he also worked in the competitive intelligence franchise at WNS, a (GSK unit). He has over 12 years of experience in oncology, immunology, neurology and rare disease consulting, insights generation, scientific analytics and KOL management. At Prescient, Gaurav has been instrumental in guiding product, clinical and commercial strategy analyses.

Sanam is a Director at Prescient. Following her bachelor’s degree in anatomy and physiology, she completed her DPhil in clinical neuroscience at Green Templeton College, University of Oxford, then spent over seven years in consulting roles at IQVIA, leveraging real-world data to generate insights for biopharma companies preparing for commercial launches of their novel therapies.

Sanam has extensive expertise in precision medicine, oncology and rare diseases, with a focus on health informatics, clinical operations and the use of novel technology platforms to access clinical data and deliver observational studies. She is also experienced in building public-private partnerships and evidence networks for translational research.

Based in London, Sanam partners with key biopharma stakeholders on asset-level evidence planning, study concept development and real-world data landscaping, design and study implementation.

Shweta is a Director at Prescient. She has an MBA in pharmaceutical management from the National Institute of Pharmaceutical Education and Research (NIPER) and worked with IMS Health (now IQVIA) and SmartAnalyst India prior to joining Prescient. With more than 15 years of experience in oncology research and analytics, consulting, and database tool management, she delivers disease area-based clinical trial analytics, competitive landscapes and datasets supporting our product, commercial and therapy area strategy analyses. Shweta is an expert in clinical trial analysis and insight generation and has been extensively involved in the conceptualization, structuring and process layouts for multiple cancer reports and datasets in both solid and hematological malignancies. She is responsible for our secondary Data & Analytics solid tumors portfolio.

Reena is a Director at Prescient. In addition to her medical degree, she holds a postgraduate certificate in the quality and accreditation of health care organizations. Prior to joining Prescient, Reena practiced as a physician then transitioned into working with various pharmaceutical companies. With more than a decade of clinical and pharmaceutical industry experience, Reena’s expertise spans consulting, medical affairs, clinical development and medical writing across a range of therapy areas. At Prescient, Reena leads multi-dimensional engagements for global pharmaceutical organizations to support their business intelligence strategies across various stages of the product life cycle.

Nick is a Senior Director at Prescient. He has a PhD in pharmacology from the University of London and was a senior postdoctoral research fellow in the Department of Clinical Pharmacology at London’s Royal Postgraduate Medical School. Nick’s career in the pharmaceutical industry has encompassed senior scientist roles leading discovery pharmacology in projects for airway diseases at Rhône-Poulenc (now Sanofi) and asthma and type 2 diabetes at SmithKline Beecham (now GSK). He then spent nearly 19 years as a senior equity analyst, covering the European pharmaceutical and biotechnology sectors. At Prescient, Nick supports our clients as a subject matter expert in oncology, respiratory disease and type 2 diabetes.

Christian is a Director and leads our Munich office. After studying physics and completing his PhD in molecular biology at ETH Zurich, he worked as a research associate at Harvard Medical School for three years. Christian then held consulting roles at BCG, Syneos Health and Trinity Life Sciences. Recently, his work has focused on supporting biopharma companies as they prepare for the commercial launches of novel therapies in Europe. He is skilled in working with cross-functional teams and leveraging his experience in commercial, medical affairs and market access. Christian has extensive experience across therapeutic areas, with a focus on rare diseases and novel technology platforms, including cell and gene therapies. At Prescient, Christian is responsible for building our German team and cultivating an office culture that supports the growth of our European business.

Diane is our Head of Learning. She holds an MSc in management learning from Lancaster University, is a fellow of the Learning and Performance Institute (LPI) and a chartered member of the Chartered Institute of Personnel and Development (CIPD). She brings a wealth of global learning experience across several sectors from her previous corporate and consultancy roles in leadership and management development. She has worked in professional services for the last 10 years building consulting, leadership, professional and business development capabilities. Diane is responsible for building out Prescient Academy, a program focused on developing critical skills that enable us to offer world-class service to our clients and development pathways to our talented team members.

Dan is a Consulting Director at Prescient with over 10 years of experience in global, regional and UK market research in addition to brand strategy. He has worked in a broad range of therapeutic areas, including oncology, rare diseases, immunology, vaccines and metabolic diseases, amongst others, supporting both pre-launch and in-line brands. Dan’s collaborative working style with clients, as well as his desire to uncover behavioral drivers across HCPs, patients and payers, enables him to focus on the small details that enhance brand strategy. He is motivated by building longstanding partnerships and facilitating action-orientated workshops, using insights to navigate through complexity and providing a springboard to action. In July 2022, Dan became a Board member of the British Healthcare Business Intelligence Association (BHBIA).

Sudhir is a Director at Prescient. He has a master’s degree in pharmacy and is a registered pharmacist. He has over 10 years of experience in strategic consulting and competitive intelligence, particularly in oncology, inflammation and biosimilars/generics. He has expertise across various forms of engagements, but his primary strategic areas of focus are asset life cycle and portfolio/therapeutic area planning. At Prescient, Sudhir serves as a critical thought partner for clients, managing key accounts, and building and coaching the Prescient team.

Yasemin is a Director at Prescient. She has more than 10 years of experience in the pharmaceutical industry supporting products and portfolios from clinical drug development to commercialization and delivering evidence-based clinical, regulatory and commercial strategy analyses for marketed and pipeline products. Yasemin has extensive experience in oncology and has worked across a range of other therapeutic areas, including rare diseases and immunology. At Prescient, Yasemin leads key global oncology accounts and drives business growth.

Maksim is a Director at Prescient. He earned his PSM in biotechnology from Temple University, where he gained an advanced understanding of industries across the life sciences sector. At Prescient, Maksim leverages his deep clinical and commercial knowledge to help his global clients answer complex business questions across a range of disease areas, such as hematology, rheumatology, dermatology and respiratory. He also takes on an active role in training and mentoring junior analysts, thus helping his team members achieve their personal career goals.

Ishaan joined our team in January 2021 as a Consultant. After receiving his undergraduate and master’s degrees from UCL in biology and molecular medicine, respectively, he started his career in the NHS in a variety of administrative and research positions at University College Hospital, London. He then transitioned to healthcare market research spending several years at Hall & Partners where he worked across different therapy areas. At Prescient, Ishaan actively seeks opportunities to use his research and storytelling capabilities to deliver valuable insights to our clients.

Jessica joined our team in October 2020 as our People and Culture Manager. She has gained 7 years’ experience as an HR professional after completing her degree in social psychology from Loughborough University and CIPD level 7 advanced diploma in human resource management. At Prescient, Jessica is responsible for shaping our people strategy and supporting our team to achieve their goals.

Mega is based in our New Delhi office. She completed her Master’s degree in biotechnology at Amity University. Prior to joining Prescient, she spent a decade working with pharmaceutical and medical technology companies based in India in various functional areas, including sales, marketing and business development. At Prescient, Mega has been involved in projects across various domains, including immunology, oncology, respiratory diseases and biosimilars.

Carly is based in our Jersey City office. She completed her MSc in biomedical science at the Icahn School of Medicine at Mount Sinai, where her research focused on the treatment of pulmonary hypertension through the development of a novel therapeutic and investigation into the role of miRNAs in lung pathology. Previously, she completed her BSc in neuroscience at the University of Miami. At Prescient, Carly has worked on a variety of medical affairs, market access and commercial strategy projects with and large biotech and pharmaceutical companies, specializing in various therapy areas including oncology, ophthalmology and respiratory diseases.

Sonia is based in our Barcelona office. She holds a PhD in biochemistry and microbiology from Imperial College London and an MSc in infectious diseases from University College London. Prior to joining Prescient, she worked as an associate at Imperial Consulting Group where she devised the market entry strategy for a point-of-care diagnostic test for infectious diseases. She has published four papers in peer-reviewed journals, been an invited speaker at international conferences and won multiple scholarships and awards. At Prescient, Sonia leads projects involving competitive landscape and commercial strategy analysis, including launch strategies across multiple therapeutic areas.

Melanie is based in our San Mateo office. She has completed her PhD in cell and molecular biology at the University of Pittsburgh in collaboration with the Massachusetts Institute of Technology. Following her PhD, she received the Wound Healing Foundation’s 3M Fellowship and became an Instructor at Stanford University School of Medicine. She then worked at Orca Bio, developing bone marrow transplants for patients with certain high-risk blood cancers. She has 14 years of experience working in the cell therapy space and has contributed to over 40 publications in regenerative medicine. At Prescient, Melanie oversees competitive intelligence projects in cell therapy and oncology.

Ishita is based in our New Delhi office. She has completed her diploma and degree in aircraft maintenance engineering from Singhania University and her Master’s degree in aviation management from ICFAI University. Prior to joining Prescient, she supported technology offerings within a pharma startup company. At Prescient, she works diligently on optimizing our InflexionRx® platform for internal and external users and supports consistent and creative UX/UI experiences.